Northwest Biotherapeutics reported $116.13M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Applied Genetic Technologies AGTC:US USD 26.6M 1.4M
AstraZeneca AZN:LN USD 24.85B 3.04B
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Celldex Therapeutics CLDX:US USD 16.29M 13.66M
Cti Biopharma CTIC:US USD 29.77M 19K
Cytori Therapeutics CYTX:US USD 7.42M 449K
Cytrx CYTR:US USD 3.1M 633.56K
Eisai 4523:JP JPY 266.54B 35.36B
Genocea Biosciences GNCA:US USD 18.03M 653K
Infinity Pharmaceuticals INFI:US USD 14.2M 139K
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Northwest Biotherapeutics NWBO:US USD 116.13M 17.97M